Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndromeIgnacio Cruz‐González, Ik‐Kyung Jang, Hikari Watanabe et al.|Journal of Thrombosis and Thrombolysis|2007Cited by 30
What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?Ignacio Cruz‐González, Ik‐Kyung Jang, María Sánchez Ledesma et al.|Blood Coagulation & Fibrinolysis|2008Cited by 9